Philipp M Altrock

24PUBLICATIONS
83CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyLife histories
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 29, 2026
Quantifying target antigen-dependent CAR T-cell performance against AML.

|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|Nov 20, 2025
Beyond Expansion: Tumor Debulking as Key to Improving CAR T-Cell Potential in Lymphoma.

Philipp M Altrock

|May 02, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers.

Bina Desai, Tatiana Miti, Sandhya Prabhakaran

|Jan 03, 2025
Integration of Immune Cell-Target Cell Conjugate Dynamics Changes the Time Scale of Immune Control of Cancer.

Qianci Yang, Arne Traulsen, Philipp M Altrock

|May 07, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators.

Bina Desai, Tatiana Miti, Sandhya Prabhakaran

Pageof 4

Frequent Collaborators

6 joint publications

Andriy Marusyk

5 joint publications

Gregory J Kimmel

5 joint publications

Daria Miroshnychenko

4 joint publications

Marylin Bui